Recurrent mutations ofCD79BandMYD88are the hallmark of primary central nervous system lymphomas-Reference-Cited by-同舟云学术

Recurrent mutations ofCD79BandMYD88are the hallmark of primary central nervous system lymphomas

Published:2015-07-20 Issue:3 Volume:42 Page:279-290
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathol Appl Neurobiol

Author:

Nakamura T.¹²,Tateishi K.¹²,Niwa T.³,Matsushita Y.⁴,Tamura K.⁵,Kinoshita M.⁶,Tanaka K.⁷,Fukushima S.¹,Takami H.¹,Arita H.⁴⁶,Kubo A.⁸,Shuto T.⁹,Ohno M.⁴,Miyakita Y.⁴,Kocialkowski S.¹⁰,Sasayama T.⁷,Hashimoto N.⁶,Maehara T.⁵,Shibui S.⁴,Ushijima T.³,Kawahara N.²,Narita Y.⁴,Ichimura K.¹

Affiliation:

1. Division of Brain Tumor Translational Research; National Cancer Center Research Institute; Tokyo Japan

2. Department of Neurosurgery; Graduate School of Medicine; Yokohama City University; Yokohama Japan

3. Division of Epigenomics; National Cancer Center Research Institute; Tokyo Japan

4. Department of Neurosurgery and Neuro-oncology; National Cancer Center; Tokyo Japan

5. Department of Neurosurgery; Tokyo Medical and Dental University; Tokyo Japan

6. Department of Neurosurgery; Graduate School of Medicine; Osaka University; Osaka Japan

7. Department of Neurosurgery; Graduate School of Medicine; Kobe University; Kobe Japan

8. Department of Neurosurgery; Yokosuka Kyosai Hospital; Yokosuka Japan

9. Department of Neurosurgery; Yokohama Rosai Hospital; Yokohama Japan

10. Department of Pathology; University of Cambridge; Cambridge UK

Funder

National Cancer Center

Publisher

Wiley

Subject

Physiology (medical),Clinical Neurology,Neurology,Histology,Pathology and Forensic Medicine

Reference28 articles.

1. Kluin P Deckert M Ferry J Primary diffuse large B-cell lymphoma of the CNS 2008

2. The Committee of Brain Tumor Registry of Japan reported. And the chairman of The Committee of Brain Tumor Registry of Japan is Soichiro Shibui;Neurologia medico-chirurgica,2014

3. Recent developments in the treatment of aggressive non-Hodgkin lymphoma;Michallet;Blood Rev,2009

4. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing;Lohr;Proc Natl Acad Sci U S A,2012

5. Analysis of the coding genome of diffuse large B-cell lymphoma;Pasqualucci;Nat Genet,2011

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Research Platform for Malignant Central Nervous System Tumors;Neurologia medico-chirurgica;2024-09-15

2. A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma;Clinical Cancer Research;2024-07-12

3. Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10;The Lancet Haematology;2024-07

4. Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System;Anticancer Research;2024-06-26

5. A systematic review of primary central nervous system lymphoma;Holistic Integrative Oncology;2024-05-11